William Grossman, Chief Medical Officer at Arcus Biosciences, Inc. (RCUS), bought 400 shares at $8.00 ($3K) on 2019-10-14, disclosed to the SEC on 2019-10-15.
Open-market purchase of $3k RCUS by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 100 | $800 | 25.0% |
| 2 | $8.00 | 300 | $2K | 75.0% |
| Total | $8.00 avg | 400 | $3K | 100% |
| Filing → |
| RCUS | SELL | 2021-04-26 | $259K | — | Filing → |
| RCUS | SELL | 2021-03-18 | $149K | — | Filing → |
| RCUS | SELL | 2020-12-18 | $133K | — | Filing → |